What is the routine blood test workup for a 60-year-old patient with thrombocytopenia?

Routine Blood Test Workup for a 60-Year-Old Patient with Thrombocytopenia

In a 60-year-old patient with thrombocytopenia, you must obtain a complete blood count (CBC) with peripheral blood smear examination, comprehensive metabolic panel including creatinine and liver function tests, coagulation profile (PT/INR, aPTT), direct antiglobulin test (DAT), HIV and hepatitis C serology, and ADAMTS13 activity level, with strong consideration for bone marrow examination given the patient's age. 1

Essential Initial Laboratory Tests

Core Blood Tests (Must Obtain)

Complete Blood Count (CBC) with Differential:

• Confirm true thrombocytopenia vs. pseudothrombocytopenia by repeating in heparin or sodium citrate tube if EDTA-dependent platelet clumping suspected 2, 1
• Assess for isolated thrombocytopenia vs. pancytopenia
• Check hemoglobin/hematocrit for anemia (if present, calculate reticulocyte count to distinguish hemolysis from blood loss) 1
• Evaluate white blood cell count and differential for lymphoproliferative disorders

Peripheral Blood Smear (Critical - Must Be Reviewed by Hematologist/Pathologist):

• Look for schistocytes (suggests TTP/TMA - particularly important in patients ≥60 years who have delayed diagnosis) 3
• Identify platelet size abnormalities (giant or small platelets suggest inherited thrombocytopenia) 1
• Exclude leukocyte inclusion bodies (MYH9-related disease) 1
• Confirm absence of platelet clumping 2, 1

Critical Tests for Life-Threatening Conditions

ADAMTS13 Activity Level:

• Must be drawn BEFORE any plasma exchange if TTP suspected 3
• Activity <10% confirms TTP with 97% sensitivity and 100% specificity 3
• Particularly critical in patients ≥60 years who present with atypical features (less profound anemia/thrombocytopenia, more severe renal/cardiac involvement) 3

Coagulation Profile:

• PT/INR and aPTT (normal in ITP and TTP; abnormal suggests DIC or other coagulopathy) 3
• Fibrinogen and D-dimer if DIC suspected

Direct Antiglobulin Test (DAT/Coombs):

• Nearly always negative in TTP 3
• Positive suggests autoimmune hemolytic anemia or Evans syndrome

Organ Function and Secondary Cause Assessment

Comprehensive Metabolic Panel:

• Creatinine and BUN: Mild-to-moderate elevation suggests TTP; severe elevation suggests other TMA 3
• Liver function tests (AST, ALT, bilirubin, alkaline phosphatase): Elevated indirect bilirubin suggests hemolysis; hepatic dysfunction suggests liver disease-related thrombocytopenia 2, 1
• Urinalysis for proteinuria, hematuria, hemoglobinuria 3

Infectious Disease Screening:

• HIV serology (mandatory regardless of risk factors) 1
• Hepatitis C serology (mandatory regardless of risk factors) 1
• Both can present identically to primary ITP and may achieve remission with infection control 1

Age-Specific Mandatory Test

Bone Marrow Examination (Aspirate and Biopsy):

• Strongly recommended in all patients >60 years with thrombocytopenia 1
• Include morphologic assessment, flow cytometry, and cytogenetic testing 1
• Flow cytometry particularly helpful for identifying CLL-associated ITP 1
• Rules out myelodysplastic syndromes, leukemias, and other marrow pathology common in this age group

Additional Tests Based on Clinical Context

If TMA/TTP Features Present (Schistocytes, Organ Dysfunction)

Cardiac Assessment:

• Troponin (repeat daily during acute episode - elevation predicts mortality even without cardiac symptoms) 3
• BNP or NT-proBNP for heart failure 3
• ECG and echocardiogram 3

Renal Assessment:

• Creatinine-to-albumin ratio 3
• Serial creatinine monitoring

Neurologic Assessment:

• Document baseline neurologic examination and funduscopic exam 2

If ITP Suspected

Helicobacter pylori Testing:

• Urea breath test or stool antigen test (preferred over serology) 1
• Consider in all adults with typical ITP where treatment may have clinical impact 1

Thyroid Function:

• TSH, free T4, thyroglobulin antibodies, thyroid peroxidase antibodies 1
• 8-14% of ITP patients develop clinical thyroid disease longitudinally 1

Tests NOT Routinely Recommended

• Antiplatelet antibody assays (PaIgG elevated in both immune and non-immune thrombocytopenia) 1
• Antiphospholipid antibodies (unless symptoms of antiphospholipid syndrome present) 1
• Antinuclear antibodies (unless clinical features suggest lupus) 1

Critical Clinical Pitfalls in 60-Year-Old Patients

1. Delayed TTP diagnosis is common in patients ≥60 years: Median time to diagnosis is 3 days vs. 1 day in younger patients 3
2. Atypical TTP presentations are more frequent: Less profound thrombocytopenia (may be ≥30×10⁹/L), more severe renal/cardiac involvement, delirium rather than focal neurologic deficits 3
3. Higher malignancy risk: Bone marrow examination is essential to exclude myelodysplasia and lymphoproliferative disorders 1
4. Absence of schistocytes does not rule out TTP: They may be initially inapparent 3